4//SEC Filing
Allouche Cyril 4
Accession 0001479290-18-000114
CIK 0001479290other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 8:59 PM ET
Size
8.3 KB
Accession
0001479290-18-000114
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Sale
Common Stock
2018-11-09$23.72/sh−2,188$51,899→ 4,750 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-09−2,188→ 7,500 totalExercise: $13.35Exp: 2026-10-30→ Common Stock (2,188 underlying) - Exercise/Conversion
Common Stock
2018-11-09$13.35/sh+2,188$29,210→ 6,938 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche.
- [F2]The Option vests in accordance to the following schedule: 25% on the first anniversary of the vesting commencement date of October 31, 2016, and 1/48th vesting each month thereafter for the remaining three years, subject to Mr. Allouche's Continuous Service (as defined in the Plan) as of such date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 8:59 PM ET
- Size
- 8.3 KB